Cargando…
German Multicenter Study Analyzing Antimicrobial Activity of Ceftazidime-Avibactam of Clinical Meropenem-Resistant Pseudomonas aeruginosa Isolates Using a Commercially Available Broth Microdilution Assay
Multidrug resistance is an emerging healthcare issue, especially concerning Pseudomonas aeruginosa. In this multicenter study, P. aeruginosa isolates with resistance against meropenem detected by routine methods were collected and tested for carbapenemase production and susceptibility against ceftaz...
Autores principales: | Manzke, Jana, Stauf, Raphael, Neumann, Bernd, Molitor, Ernst, Hischebeth, Gunnar, Simon, Michaela, Jantsch, Jonathan, Rödel, Jürgen, Becker, Sören L., Halfmann, Alexander, Wichelhaus, Thomas A., Hogardt, Michael, Serr, Annerose, Hess, Christina, Wendel, Andreas F., Siegel, Ekkehard, Rohde, Holger, Zimmermann, Stefan, Steinmann, Jörg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137722/ https://www.ncbi.nlm.nih.gov/pubmed/35625189 http://dx.doi.org/10.3390/antibiotics11050545 |
Ejemplares similares
-
Comparative Evaluation of Vitek 2 and Etest versus Broth Microdilution for Ceftazidime/Avibactam and Ceftolozane/Tazobactam Susceptibility Testing of Enterobacterales and Pseudomonas aeruginosa
por: Papadomanolaki, Arhodoula, et al.
Publicado: (2022) -
Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against Enterobacterales Clinical Isolates
por: Han, Renru, et al.
Publicado: (2022) -
Ceftazidime–Avibactam versus Meropenem for the Treatment of Complicated Intra-Abdominal Infections
por: Tan, Che-Kim, et al.
Publicado: (2019) -
In vivo translational assessment of the GES genotype on the killing profile of ceftazidime, ceftazidime/avibactam and meropenem against Pseudomonas aeruginosa
por: Gill, Christian M, et al.
Publicado: (2022) -
Ceftazidime-avibactam
por: Matesanz, Mayra, et al.
Publicado: (2021)